For instance, in triple-negative breast cancer and melanoma models, ERβ enhances the TCR signaling pathway (such as Zap70/Lck phosphorylation) in CD8+ T cells through the tyrosine phosphorylation switch, promoting T cell activation and anti-tumor cytokine secretion in a non-genomic manner (65). Here, CD8A is linked to melanoma.